These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33175110)

  • 41. Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients.
    Odeti S; Yellepeddi VK
    Am Fam Physician; 2021 Sep; 104(3):311-312. PubMed ID: 34523893
    [No Abstract]   [Full Text] [Related]  

  • 42. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 5.
    Frishman WH
    Cardiol Rev; 2021 May-Jun 01; 29(3):109. PubMed ID: 33758124
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of COVID-19 in high-risk outpatients.
    Med Lett Drugs Ther; 2022 Feb; 64(1643):e1. PubMed ID: 35134051
    [No Abstract]   [Full Text] [Related]  

  • 44. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 45. The race against COVID-19.
    Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
    [No Abstract]   [Full Text] [Related]  

  • 46. The race for antiviral drugs to beat COVID - and the next pandemic.
    Dolgin E
    Nature; 2021 Apr; 592(7854):340-343. PubMed ID: 33854246
    [No Abstract]   [Full Text] [Related]  

  • 47. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 48. Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Miller MC; Forciea MA; Humphrey LL;
    Ann Intern Med; 2021 Dec; 174(12):W116-W117. PubMed ID: 34606308
    [No Abstract]   [Full Text] [Related]  

  • 49. Ebola.
    Feldmann H; Sprecher A; Geisbert TW
    N Engl J Med; 2020 May; 382(19):1832-1842. PubMed ID: 32441897
    [No Abstract]   [Full Text] [Related]  

  • 50. Remdesivir for the Treatment of COVID-19.
    Allen R; Turner M; deSouza IS
    Am Fam Physician; 2022 Feb; 105(2):131-132. PubMed ID: 35166509
    [No Abstract]   [Full Text] [Related]  

  • 51. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
    Watanabe JH; Kwon J; Nan B; Abeles SR; Jia S; Mehta SR
    JAMA Netw Open; 2021 May; 4(5):e2110775. PubMed ID: 34019090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis.
    Tempestilli M; Stazi GV; Maffongelli G; Marini MC; Ascoli Bartoli T; Ippolito G; Nicastri E; Marchioni L; Agrati C
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1583-1585. PubMed ID: 33982133
    [No Abstract]   [Full Text] [Related]  

  • 53. Kidney Transplantation and COVID-19.
    Merhi B; Gohh R
    R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010
    [No Abstract]   [Full Text] [Related]  

  • 54. Major Update 2: Remdesivir for Adults With COVID-19.
    Finsterer J
    Ann Intern Med; 2022 Aug; 175(8):W81. PubMed ID: 35969872
    [No Abstract]   [Full Text] [Related]  

  • 55. Major Update 2: Remdesivir for Adults With COVID-19.
    Kaka AS; Wilt TJ
    Ann Intern Med; 2022 Aug; 175(8):W81-W82. PubMed ID: 35969873
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 Therapeutics for Nonhospitalized Patients.
    Gandhi RT; Malani PN; Del Rio C
    JAMA; 2022 Feb; 327(7):617-618. PubMed ID: 35029659
    [No Abstract]   [Full Text] [Related]  

  • 57. A survey of US hospitals' criteria for the allocation of remdesivir to treat COVID-19.
    Mun F; Hale CM; Hennrikus EF
    Am J Health Syst Pharm; 2021 Jan; 78(3):235-241. PubMed ID: 33289021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remdesivir (Veklury) for COVID-19.
    Med Lett Drugs Ther; 2020 Nov; 62(1612):186-188. PubMed ID: 33443491
    [No Abstract]   [Full Text] [Related]  

  • 59. Audio Interview: A Potential New Agent to Treat Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(26):e101. PubMed ID: 34936745
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea.
    Carnevale S; Beretta P; Morbini P
    J Med Virol; 2021 Jan; 93(1):61-63. PubMed ID: 32492199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.